Buy Avenue Therapeutics Stock | ATXI Stock Price & Latest News | Public
ATXI

Avenue Therapeutics

$0.00 (0.00%)Today
    Small Market Cap

    About ATXI

    Avenue Therapeutics, Inc. engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, which is intended for the treatment of moderate to moderately sever...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.04
    -0.08
    -0.12
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.06

    Actual EPS
    Q4 2020

    Stats

    Market Cap$56,27M
    Volume2,73k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$12.34
    1 Year Low$2.85
    Open$3.40
    High$3.40
    Low$3.29

    Buy any stock with any amount of money.

    Download the App
    Download the app